Sanofi's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 5.55, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Sanofi in Dec 31 2025 quarter, has decreased to 66 days, compared to 68 days, in the 0 quarter.

If we take a look into Healthcare sector 459 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 3128 to 3219.

What is Receivable Turnover Ratio?
What is Sanofi Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SNY Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	9.55 %	9.55 %	3.34 %	9.55 %	-8.96 %
Y / Y Revenue Change	5.49 %	-	-	-	-4.65 %
Receivable Turnover Ratio (TTM)	5.55	5.38	5.51	5.55	5.68
SNY's Total Ranking	# 3219	# 3128	#	#	#
Accounts Receivable average collection period days	66	68	66	66	64
Seq. Receivable Change	0 %	0 %	0 %	9.55 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 149
Healthcare Sector	# 460
Overall Market	# 3219

Receivable Turnover Ratio Statistics
High	Average	Low
3.99	3.07	2.01
(Dec 31 2023)		(Dec 31 2020)

SNY Company Profile • Back to SNY Efficiency Comparisons • Compare SNY Receivables Turnover Ratio to its Competitors

Financial Statements
Sanofi's Accounts Receivable	$ 9,419 Millions	Visit SNY's Balance sheet
Sanofi's Sales TTM	$ 52,321 Millions	Visit SNY's Income Statement
Sources of SNY's Revenues		Visit SNY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SNY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SNY's Growth Rates	SNY's Roa	SNY's Inventory Turnover Ratio	SNY's Dividend Comparisons
SNY's Profitability Ratios	SNY's Roi	SNY's Asset Turnover Ratio	SNY's Dividend Growth
SNY's Valuation Ratios	SNY's Roe	SNY's Financial Strength Ratios	SNY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Nanobiotix S a	15.26	$ 36.504 Millions	$ 2.392 Millions
Gsk Plc	15.21	$ 32,667.000 Millions	$ 2,148.000 Millions
Precipio inc	15.02	$ 24.049 Millions	$ 1.601 Millions
Innoviva Inc	14.98	$ 384.667 Millions	$ 25.683 Millions
Qhslab Inc	14.47	$ 2.692 Millions	$ 0.186 Millions
Arbutus Biopharma Corp	14.04	$ 14.083 Millions	$ 1.003 Millions
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Aim Immunotech Inc	13.54	$ 0.088 Millions	$ 0.007 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.18	$ 52.149 Millions	$ 3.957 Millions
Nexgel Inc	13.17	$ 10.509 Millions	$ 0.798 Millions
China Pharma Holdings Inc	13.14	$ 4.144 Millions	$ 0.315 Millions
Milestone Scientific Inc	12.98	$ 8.408 Millions	$ 0.648 Millions
Dbv Technologies S a	12.63	$ 5.683 Millions	$ 0.450 Millions
Mannkind Corporation	12.49	$ 348.966 Millions	$ 27.948 Millions
Safe Pro Group Inc	12.46	$ 0.607 Millions	$ 0.049 Millions
Icu Medical Inc	12.35	$ 2,231.262 Millions	$ 180.620 Millions
Ensysce Biosciences Inc	12.27	$ 5.067 Millions	$ 0.413 Millions
Neuroone Medical Technologies Corp	12.24	$ 8.716 Millions	$ 0.712 Millions
Skinhealth Systems Inc	12.08	$ 300.364 Millions	$ 24.872 Millions
Ptc Therapeutics inc	11.92	$ 1,730.655 Millions	$ 145.207 Millions
Corcept Therapeutics Inc	11.91	$ 761.407 Millions	$ 63.950 Millions
Option Care Health Inc	11.86	$ 5,648.895 Millions	$ 476.492 Millions
Bioharvest Sciences Inc	11.83	$ 34.508 Millions	$ 2.916 Millions
Cytokinetics Incorporated	11.74	$ 88.039 Millions	$ 7.499 Millions
Teladoc Health Inc	11.74	$ 2,529.977 Millions	$ 215.496 Millions
Lifestance Health Group Inc	11.71	$ 1,424.285 Millions	$ 121.659 Millions
Chemed Corporation	11.65	$ 2,529.978 Millions	$ 217.224 Millions
Orthofix Medical Inc	11.58	$ 822.017 Millions	$ 71.016 Millions

Date modified: 2026-06-24T10:07:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.